Ricardo Camacho

6.5k total citations · 1 hit paper
91 papers, 3.2k citations indexed

About

Ricardo Camacho is a scholar working on Virology, Infectious Diseases and Hepatology. According to data from OpenAlex, Ricardo Camacho has authored 91 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Virology, 73 papers in Infectious Diseases and 14 papers in Hepatology. Recurrent topics in Ricardo Camacho's work include HIV Research and Treatment (79 papers), HIV/AIDS drug development and treatment (70 papers) and HIV/AIDS Research and Interventions (41 papers). Ricardo Camacho is often cited by papers focused on HIV Research and Treatment (79 papers), HIV/AIDS drug development and treatment (70 papers) and HIV/AIDS Research and Interventions (41 papers). Ricardo Camacho collaborates with scholars based in Portugal, Belgium and United States. Ricardo Camacho's co-authors include Anne–Mieke Vandamme, Koen Deforche, Ana Abecasis, David van de Vijver, Charles A. Boucher, Rami Kantor, Robert W. Shafer, Perpétua Gómes, Soo‐Yon Rhee and Jonathan Schapiro and has published in prestigious journals such as SHILAP Revista de lepidopterología, Bioinformatics and PLoS ONE.

In The Last Decade

Ricardo Camacho

90 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 Update

2009 731 citations Ricardo Camacho, Rami Kantor et al. PLoS ONE profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ricardo Camacho Portugal	25	2.7k	2.7k	604	317	238	91	3.2k
Diane Descamps France	35	3.1k 1.2×	3.3k 1.2×	693 1.1×	283 0.9×	226 0.9×	140	3.8k
África Holguín Spain	27	1.5k 0.6×	1.7k 0.6×	575 1.0×	245 0.8×	153 0.6×	116	2.3k
Michael J. Kozal United States	29	2.0k 0.8×	2.4k 0.9×	607 1.0×	646 2.0×	149 0.6×	57	3.1k
Jean‐Christophe Plantier France	31	2.2k 0.8×	2.1k 0.8×	964 1.6×	248 0.8×	271 1.1×	123	3.0k
Florence Damond France	34	3.0k 1.1×	2.8k 1.0×	774 1.3×	332 1.0×	173 0.7×	117	3.5k
Winnie Dong Canada	25	1.5k 0.6×	1.6k 0.6×	413 0.7×	287 0.9×	109 0.5×	59	2.0k
Eric Sanders‐Buell United States	26	2.4k 0.9×	1.9k 0.7×	607 1.0×	413 1.3×	205 0.9×	69	2.7k
Wouter Janssens Belgium	28	2.0k 0.7×	1.6k 0.6×	486 0.8×	283 0.9×	158 0.7×	76	2.2k
Philippe Bürgisser Switzerland	30	1.5k 0.6×	1.8k 0.7×	688 1.1×	202 0.6×	557 2.3×	64	2.5k
Charlotte Charpentier France	24	1.2k 0.5×	1.4k 0.5×	439 0.7×	250 0.8×	101 0.4×	117	1.9k

Countries citing papers authored by Ricardo Camacho

Since Specialization

Citations

This map shows the geographic impact of Ricardo Camacho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ricardo Camacho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ricardo Camacho more than expected).

Fields of papers citing papers by Ricardo Camacho

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ricardo Camacho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ricardo Camacho. The network helps show where Ricardo Camacho may publish in the future.

Co-authorship network of co-authors of Ricardo Camacho

This figure shows the co-authorship network connecting the top 25 collaborators of Ricardo Camacho. A scholar is included among the top collaborators of Ricardo Camacho based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ricardo Camacho. Ricardo Camacho is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pimentel, Victor, Marta Pingarilho, Sandra Bianchini Fernandes, et al.. (2022). Differential patterns of post-migration HIV-1 infection acquisition among Portuguese immigrants of different geographical origin. Revista de Estudos Anglo-Portugueses/Journal of Anglo-Portuguese Studies. 3 indexed citations

Pingarilho, Marta, Victor Pimentel, Sandra Bianchini Fernandes, et al.. (2020). Increasing Prevalence of HIV-1 Transmitted Drug Resistance in Portugal: Implications for First Line Treatment Recommendations. Viruses. 12(11). 1238–1238. 11 indexed citations

Pimentel, Victor, Marta Pingarilho, Sandra Fernandes, et al.. (2020). Molecular Epidemiology of HIV-1 Infected Migrants Followed Up in Portugal: Trends between 2001–2017. Viruses. 12(3). 268–268. 13 indexed citations

Pineda-Peña, Andrea-Clemencia, Marta Pingarilho, Guangdi Li, et al.. (2019). Drivers of HIV-1 transmission: The Portuguese case. PLoS ONE. 14(9). e0218226–e0218226. 8 indexed citations

Sousa, João, Marina Padrão Temudo, Barry S. Hewlett, et al.. (2016). Male Circumcision and the Epidemic Emergence of HIV-2 in West Africa. PLoS ONE. 11(12). e0166805–e0166805. 9 indexed citations

Antunes, Francisco, et al.. (2015). Development of Nevirapine Resistance in Children Exposed to the Prevention of Mother-to-Child HIV-1 Transmission Programme in Maputo, Mozambique. PLoS ONE. 10(7). e0131994–e0131994. 11 indexed citations

Theys, Kristof, Ricardo Camacho, Perpétua Gómes, Anne–Mieke Vandamme, & Soo‐Yon Rhee. (2015). Predicted residual activity of rilpivirine in HIV-1 infected patients failing therapy including NNRTIs efavirenz or nevirapine. Clinical Microbiology and Infection. 21(6). 607.e1–607.e8. 14 indexed citations

Abecasis, Ana, José Poças, Fernando Maltêz, et al.. (2014). HIV-2 Integrase Polymorphisms and Longitudinal Genotypic Analysis of HIV-2 Infected Patients Failing a Raltegravir-Containing Regimen. PLoS ONE. 9(3). e92747–e92747. 17 indexed citations

Vandamme, Anne–Mieke, Ricardo Camacho, Francesca Ceccherini‐Silberstein, et al.. (2011). European recommendations for the clinical use of HIV drug resistance testing: 2011 update.. PubMed. 13(2). 77–108. 104 indexed citations

10.

Faria, Nuno R., Marc A. Suchard, Ana Abecasis, et al.. (2011). Phylodynamics of the HIV-1 CRF02_AG clade in Cameroon. Infection Genetics and Evolution. 12(2). 453–460. 49 indexed citations

11.

Abecasis, Ana, Kristel Van Laethem, Koen Deforche, et al.. (2008). Impact of HIV-1 protease mutations A71V/T and T74S on M89I/V-mediated protease inhibitor resistance in subtype G isolates. Journal of Antimicrobial Chemotherapy. 61(6). 1201–1204. 14 indexed citations

12.

Deforche, Koen, Ricardo Camacho, Marcelo A. Soares, et al.. (2008). Bayesian network analyses of resistance pathways against efavirenz and nevirapine. AIDS. 22(16). 2107–2115. 20 indexed citations

13.

Abecasis, Ana, Philippe Lemey, Nicole Vidal, et al.. (2007). Recombination Confounds the Early Evolutionary History of Human Immunodeficiency Virus Type 1: Subtype G Is a Circulating Recombinant Form. Journal of Virology. 81(16). 8543–8551. 68 indexed citations

14.

Deforche, Koen, Ricardo Camacho, Kristel Van Laethem, et al.. (2007). Estimating the Relative Contribution of dNTP Pool Imbalance and APOBEC3G/3F Editing to HIV Evolution In Vivo. Journal of Computational Biology. 14(8). 1105–1114. 25 indexed citations

15.

Vandamme, Anne–Mieke, Koen Deforche, Kristel Van Laethem, & Ricardo Camacho. (2005). HIV-1 subtype A1, C, F and G strains have a higher tipranavir mutation score than subtype B strains. Antiviral Therapy. 10(4). 2 indexed citations

16.

Camacho, Ricardo, et al.. (2005). Different substitutions under drug pressure at protease codon 82 in HIV-1 subtype G compared to subtype B infected individuals including a novel 182M resistance mutation. Antiviral Therapy. 10(4). 138. 16 indexed citations

17.

Deforche, Koen, S Cassol, Mika Salminen, et al.. (2005). An automated genotyping system for analysis of HIV-1 and other microbial sequences. Computer applications in the biosciences. 21(19). 3797–3800. 412 indexed citations

18.

Abecasis, Ana, Dimitrios Paraskevis, Inês Bártolo, et al.. (2004). HIV-1 genetic variants circulation in the North of Angola. Infection Genetics and Evolution. 5(3). 231–237. 19 indexed citations

19.

Abecasis, Ana, Perpétua Gómes, Inge Derdelinckx, et al.. (2003). L891/V: a novel mutation selected by protease inhibitor therapy in subtype G, but not in subtype B-infected patients. Antiviral Therapy. 8(3). 3 indexed citations

20.

Weber, Bernard, et al.. (1999). Multicenter evaluation of a new rapid automated human immunodeficiency virus antigen detection assay. Journal of Virological Methods. 78(1-2). 61–70. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact